⌕
Twist Bioscience · TWST · Nasdaq
Tenet 37 · Weak
Compare
$111.60−2.29%At closeTenet 37 · Weak
$111.60−2.62 (−2.29%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Twist Bioscience (TWST) Stock

Twist Bioscience (TWST) closed at $111.60 on Nov 13, 2026; its Tenet Score is 37 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

19 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$111.60
Nov 13, 2026
Market cap
$7.0B
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
23.30 – 219.71
low → high
Tenet Score
37/100
Weak · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Twist Bioscience Corp scores 37/100. Weak. Value is the soft spot versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
37/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
11
Quality
41
Health
41
Growth
55

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueFQualityDHealthDGrowthCMomentumA+
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
15.7×
price to book value
P/S
16.2×
price to fiscal 2025 sales
ROE
−30%
return on equity
Operating margin
−36.2%
fiscal 2025, before interest and tax
Net margin
−31.7%
of revenue kept
Current ratio
2.67
current assets to liabilities
Net debt / EBITDA
—
Not meaningful: EBITDA is zero or negative.
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Twist Bioscience Corp

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based p…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 128 US ETFs · top wrappers by weightSee all ETFs holding TWST →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Twist Bioscience in?

Twist Bioscience is in the Healthcare sector and the Drugs industry.

What is Twist Bioscience's Tenet Score?

Twist Bioscience's Tenet Score is 37 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.